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1. Introduction 
* Corresponding author. Fax: +44 I17 9254794. 
Studies of neuronal metabolism, and interpreta- 
tions of the findings thereon, have been hampered by 
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the relative inaccessibility and heterogeneity of brain. 
Until the advent of nuclear magnetic resonance 
(NMR) technology, it was impossible to obtain a 
continuous record of events when the metabolic state 
of the brain was altered because biochemical nalyses 
on trapped tissues, which provide the necessary infor- 
mation, represent single points in time. NMR spec- 
troscopy, despite its elegance, still suffers from a lack 
of sensitivity and spatial resolution as well as the 
ability to distinguish between different compartments 
of the brain. Moreover, in studies on whole animals, 
it is virtually impossible to produce closely defined 
extracellular conditions and determine their impact 
on intracellular processes. For this reason, several 
model systems have been developed: (a) slices; (b) 
cells cultured from the CNS and (c) cells, or their 
fragments, acutely isolated from brain. Although 
much useful information has been collected in the 
first model, slices inevitably contain a certain propor- 
tion of damaged cells. Moreover, difficulties in ensur- 
ing adequate penetration of oxygen and nutrients into 
their 'inner core' may compromise the ability of 
some areas to maintain proper energetic state. In the 
vast majority of studies on cultures, the results have 
been derived from cells originating from an immature 
animal whose metabolism ay well differ from that 
in the adult. In addition, growth in media, whose 
composition and 0 2 content may change continu- 
ously, can also alter the metabolic behaviour of both 
neurons and astrocytes; markedly increased glycoly- 
sis is a well-known example of such changes. With 
respect to the last model, eflbrts to isolate undamaged 
neurons and glial cells from whole brain have met 
with little success, the main problems being the lack 
of methodology to separate the two cell types cleanly 
and inability to preserve their metabolism intact. 
Over 30 years ago Gray and Whittaker [1] and De 
Robertis and co-workers [2] introduced a preparation 
of 'nerve-endings particles' or 'synaptosomes' which 
consists of the presynaptic parts of the synapses, 
pinched-off during homogenization f the tissue. Iso- 
lated synaptosomes carry out a number of anabolic 
and catabolic reactions characteristic of intact cells as 
well as processes pecific to neurons, such as depo- 
larization in response to electrical stimulation and 
release and uptake of neurotransmitters [3,4]. During 
the past 30 years, the preparation has been used 
successfully to study metabolic pathways, relation- 
ships between energy production and ion movements, 
neurotransmitter storage and synthesis, and mecha- 
nisms involved in transmitter release. The last two 
entities have been reviewed recently [5] and several 
concepts have been discussed and ideas proposed. By 
contrast, the metabolic and energetic properties of 
synaptosomes have received much less attention in 
recent years. This is a serious oversight, because the 
key function of nerve terminals is to process informa- 
tion, an activity which is accomplished by moving 
ions continuously across the plasma membrane. A
necessary component of this is the maintenance of 
ionic disequilibria which requires a large input of 
energy. Hence the metabolic and energetic properties 
of nerve endings are intimately related to CNS func- 
tion. 
The aim of this review is to analyze critically 
information which relates to ATP generation and 
utilization in synaptosomes. It is the feeling of the 
authors that the usefulness of this preparation has 
now been fully established and it is time to provide 
an overall picture of how nerve endings operate to 
IFhlfil their role in brain. 
2. Energy parameters and ion levels in isolated 
synaptosomes 
2.1. Concentrations of high-energy phosphate com- 
pounds and rates of ATP generation 
Any valid model system should exhibit metabolic 
properties which are similar to those of the in vivo 
system which it purports to represent. One of the 
most informative of these is the ability to generate a 
high energetic state ([ATP]/[ADP][Pi] or equivalent, 
which reflects the activity of the energy-producing 
machinery) and maintain appropriate ionic gradients 
across the plasma membrane. Synaptosomal energy 
parameters are summarized in Table 1 as ranges of 
values, which encompass figures obtained in different 
laboratories over the past 15 years, predominantly on 
preparations from rat brain although values from 
guinea pig cortex are not significantly different. There 
are large variations among laboratories in reports of 
concentrations and ratios of high energy phosphate 
compounds. The former could be due to differences 
either in isolation methodologies (which might yield 
preparations with different proportions of 'contami- 
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nants') or data expression (e.g., methods used to 
quantify proteins). It is also possible that nucleotides 
are lost from synaptosomes during the 'pinching-off' 
process and are not resynthesized during in vitro 
incubations because there is a very limited capacity 
for their salvage via the purine nucleotide cycle [6]. 
The large range of [ATP]/[ADP] ratios is more diffi- 
cult to explain because these are independent of 
protein content and, therefore, of the extent of 'con- 
tamination' by non-synaptic elements. Based on a 
study in which the overall [ATP]/[ADP] was 2.18, 
Kyriazi and Basford [7] have attributed this appar- 
ently low synaptosomal energy level to an inherent 
property of the preparation. They argued that individ- 
ual synaptosomes (or populations thereof) exhibit 
different degrees of intactness and different mito- 
chondrial content and suggested that only some of the 
populations have high [ATP]/[ADP] and the capacity 
to produce nergy. Since isolated nerve ending parti- 
cles differ by their very nature in size, site of origin 
and type of terminal they come from, this proposal 
does not explain why in some laboratories prepara- 
tions can be obtained which consistently exhibit 
[ATP]/[ADP] of 6 and greater [8,9]. The latter figure 
is only marginally lower than the value of 8-10 
measured in whole, in situ frozen brain tissue (for 
review see Refs. [10-12]) and the ability to attain it 
means that, providing special precautions are taken, 
mixtures of terminals can be isolated in which the 
vast majority is metabolically fully competent and 
capable of generating a high energy state 
([ATP]/[ADP]). 
Although synaptosomes can generate an energy 
level which is comparable to that in vivo, their low 
content of nucleotides, creatine phosphate/creatine 
and slow rates of respiration and lactate generation 
(5- to 10-fold lower than those in whole brain; for 
appropriate values in vivo see Refs. [10-12]) deserve 
a comment. As discussed above, the situation may 
either be an artifact of the experimental model or an 
inherent property of nerve terminals themselves. It is 
impossible to distinguish between these alternatives, 
because no technology presently available allows col- 
lection of relevant information from individual brain 
subcompartments in vivo. However, the issue is im- 
portant because it means that a particular cell, or one 
Table l 
Values of energy parameters in brain nerve endings (synaptosomes) 
Parameter Value Reference 
ATP 1.4-5.6 nmol.  mg prot-  i 
ADP 0.4-2.5 nmol • mg prot 
[ATP]/[ADP] 1.4-6.0 
PCr 2.2-6.5 nmol - mg prot 
Cr 15-25 nmol.  mg prot t 
[PCr]/[Cr] 0.4-0.6 
0 2 uptake 2 -4  nmol • min-~ • mg prot- t at 30°C 
Lactate production 
5 .2 -11 .0nmol .min  t .mgprot  t at37°C 
0.3-0.6 nmol • min -  t . mg prot- t at 30°C 
0.8-2.7 nmol • min ~ • mg prot- J at 37°C 
De Belleroche and Bradford [3], Barberis and Mcllwain [151], 
Dagani and Erecifiska [129], Harvey et al. [152], 
Kauppinen and Nicholls [8], Ksiezak and Gibson [153], 
Kyriazi and Basford [7], Park et al. [ 154], 
Rafalowka et al. [155], Scott and Nicholls [13] 
Rafalowka et al. [ 155], Dagani and Erecifiska [129], 
Erecifiska et al. [146,156] 
Rafalowska et al. [155], Bradford and Thomas [98], 
Scott and Nicholls [13], Harvey et al. [91], 
Kyriazi and Basford [7], Dagani and Erecifiska [129], 
Erecifiska et al. [146,156], Gleitz et al. [34] 
Rafalowka et al. [155], Bradford and Thomas [98], 
Scott and Nicholls [13], Kyriazi and Basford [7], 
Dagani and Erecifiska [129], Erecifiska et al. [ 146.156], 
Gleitz et al. [34] 
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of its compartments, which has a low intrinsic capac- 
ity to generate ATP or a small content of high energy 
phosphate compounds, can have only limited energy 
reserves and its ability to produce ATP under condi- 
tions when demand is high may easily be compro- 
mised. 
In conclusion, carefully isolated synaptosomes 
generate [ATP]/[ADP] ratios only slightly lower than 
those in whole brain. However, their rate of respira- 
tion (i.e. energy formation) is considerably slower, 
and the ATP concentration substantially smaller, than 
the respective parameters in vivo. Whether this repre- 
sents a real difference between the nerve endings and 
bulk of the tissue or is an artifact of the isolation 
technique cannot be decided at present. 
2.2. Ion concentrations 
The internal evels of the key synaptosomal ions, 
based on values reported from a number of laborato- 
ries, are summarized in Table 2. The concentration f
potassium is between 45 and 65 mM at an external 
level of 4-5 mM, which yields a potassium diffusion 
potential equivalent to -50  to -60  mV; this agrees 
well with estimates of the membrane potential calcu- 
lated from the distribution of 86rubidium [13-15]. 
Internal sodium estimated from the distribution of 
22Na (after correction for trapped volume) is 25-29 
mM [16], while a much lower figure of 10.9 mM has 
been reported from the fluorescence of the indicator 
benzofuran isophthalate [17]. For comparison, in vivo 
measurements with intracellular microelectrodes show 
intraneuronal potassium to be 80-90 mM, membrane 
potential -67  mV and [Na+]i, 26 mM [12], i.e., 
figures similar to those in the isolated synaptosomes. 
Most estimates of [Ca 2+ ]i in nerve endings (0.1-0.35 
/~M; Table 2) are somewhat higher than the figures 
for neurons in brains of anesthetized rats ( < 0.1 /.LM; 
[12]); the same holds true for [H +] (7.05-7.2, Table 
2; pH i in neurons 7.35; [12]). Intrasynaptosomal 
concentration of chloride is 14 mM and of magne- 
sium, at physiological concentrations of calcium, is 
0.2-0.8 mM [18,19], again not much different from 
those in vivo. An unavoidable conclusion is that, at 
least under resting conditions, synaptosomal energy- 
generating machinery is able to maintain ionic dise- 
quilibria comparable to those in neurons of intact 
brain. 
3. Pathways of energy metabolism 
3.1. General principles 
There are two pathways in mammalian cells that 
produce energy: glycolysis, a cytosolic process, and 
mitochondrial oxidative phosphorylation. The former 
is substantially less efficient and produces 2 mol of 
ATP for each mol of glucose converted to 2 mol of 
lactate, resulting in a stoichiometric factor of 1 be- 
tween lactate and ATP. Complete combustion of 1 
mol of glucose to CO 2 and water consumes 6 mol of 
oxygen with 6 mol of ATP generated per 0 2. Glycol- 
ysis requires ADP (which is usually non-limiting 
because it is continuously produced uring anabolic 
Table 2 
Ion concentrations in brain nerve endings (synaptosomes) 
Parameter Value Reference 
[K+]i 45-65 mM 
[Na+]i 25-29 mM 
10.9 mM 
[ Ca2 + ]i 0.10-0.35 /.LM 
[Mg2+ ]i 0.2 mM " 
0.8 mM 
[H+]~ (pH) 7.05-7.20 
[C1-] i 14 mM 
Bradford [157], Blaustein [4], Pastuszko et al. [132], 
Dagani and Erecifiska [129] 
Akerman and Nicholls [16], Erecifiska et al. [158] 
Deri and Adam-Vizi [17] 
Richards et al. [159], Ashley et al. [160], 
Hansford and Castro [47] 
Heinonen and ,~kerman [18] 
Garcfa-Martln et al. [ 19] 
Richards et al. [159], White and Clark [124], 
Erecifiska et al. [146] 
Engblom and ,&kerman [ 161 ] 
a Value at 1 mM external calcium. 
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reactions) and NAD. The latter has to be regenerated 
in the cytosol from NADH which, in the presence of 
oxygen, is accomplished by the mitochondrial respi- 
ratory chain. Because the mitochondrial membrane is
impermeable to NADH, the reducing equivalents have 
to be transferred from the cytosol into the organelles 
via indirect reactions, such as the glycerol-3-phos- 
phate shuttle and the malate/aspartate shuttle. In the 
absence of oxygen, lactic dehydrogenase converts 
NADH and pyruvate to lactate and NAD. 
Under physiological conditions, the predominant 
fuel of adult mammalian brain is glucose. Only under 
very special circumstances will significant amounts 
of other substrates, e.g., ketone bodies, or amino 
acids be utilized. However, this observation is based 
on whole organ studies and does not exclude the 
possibility that there are compartments within the 
CNS which behave differently or that trafficking of 
metabolites can occur among various compartments. 
3.2. Glycolysis 
According to the modern view of metabolic on- 
trol [20,21], many, if not all, enzymes of a pathway 
exhibit activities similar to the overall rate and, de- 
pending on conditions, one or another of these mem- 
ber proteins may control overall flux. The distribution 
of the control through individual enzymes has been 
formalized in the concept of control 'strength' and 
expressed in terms of flux control coefficients [22]. 
Unfortunately, there has been no attempt to deal 
quantitatively with the distribution of the control of 
the rate of flux through glycolysis in either synapto- 
somes or the CNS. 
It is generally considered that the predominant site 
of control of glycolysis, or the step with the largest 
control coefficient, is the phosphofructokinase reac- 
tion, with some contributions from hexokinase and 
pyruvate kinase. Phosphofructokinase i  regulated in 
a very complex manner and there are over 25 known 
effectors of this enzyme [23]. The most important 
physiologically are stimulations by ADP, AMP, Pi, 
and possibly fructose-2,6-bisphosphate nd inhibi- 
tions by ATP, NH 4 citrate and H + [24-26]. Hexoki- 
nase, which is very abundant in nerve endings [27], is 
inhibited by glucose-6-phosphate and ADP and its 
activity is regulated by binding to the mitochondrial 
membrane [28]. The bound form exhibits a lower K m 
for ATP [29,30] and a higher K i for glucose-6-phos- 
phate [31]. Pyruvate kinase, the least important of the 
three regulatory enzymes, is inhibited by millimolar 
concentrations of ATP and requires potassium for 
activity [32,33]. It is of interest that calcium, an 
ubiquitous intracellular effector, is, on its own, not an 
important regulator of glycolysis. Its removal from 
anaerobic synaptosomes decreases lactate generation 
by about 40% [34]; by contrast replacement of cal- 
cium with high magnesium increased glycolytic flux 
by 50% in an aerobic, veratridine-treated preparation 
[15]. A possible explanation for the apparent discrep- 
ancy between the two studies, consistent with recent 
experiments on the role of hexokinase in the regula- 
tion of glycolysis [35], is that it is not the calcium 
itself but its effect on intracellular ATP utilization 
and level that influences lactate generation. 
Under resting conditions, and in the presence of 
oxygen, glycolysis contributes 5% or less to total 
energy generation (Table 1 and sections below). It is 
of potential consequence that several glycolytic en- 
zymes (phosphofructokinase, pyruvate kinase, al- 
dolase, glucosephosphate isomerase, glyceraldehyde- 
phosphate dehydrogenase and lactate dehydrogenase) 
show enrichment in particulate, plasma membrane- 
rich fractions which have high specific activity of 
Na /K  ATPase [36]. If this occurs in vivo, glycolyti- 
cally generated ATP could be important locally in 
supporting ion movements by the pumps. 
3.3. OxidatiL, e substrate metabolism in the nerve 
endings - the TCA cycle 
Reducing equivalents, the substrates for the mito- 
chondrial respiratory chain, are derived from 
metabolism of molecules which first enter the tricar- 
boxylic acid cycle. There are several points of entry: 
pyruvate for glucose and amino acids (alanine, serine, 
glycine, threonine and cysteine), acetylCoA for fatty 
acids, ketone bodies and amino acids (lysine, leucine, 
phenylalanine, tyrosine and tryptophan), 2-oxogluta- 
rate/oxaloacetate for glutamate, aspartate, proline, 
arginine and histidine, succinate/succinylCoA for 
GABA, valine, isoleucine and methionine and malate 
for cytosolic NADH. It is generally accepted that the 
steps of the TCA cycle with the largest control 
coefficients are citrate synthase and two calcium-reg- 
ulated dehydrogenases, i ocitrate and 2-oxoglutarate 
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dehydrogenase [37,38]. The last two enzymes, in 
addition to being activated by low concentrations of
Ca 2+, are subject to inhibition by high 
[NADH]/[NAD +] and [ATP]/[ADP] ratios [37,38]. 
Brain 2-oxoglutarate d hydrogenase, moreover, is in- 
hibited by ammonia (0.2-2 mM) and shows marked 
pH dependence, with essentially no activity below 
6.5 and above 8.6 [39]. 
Until recently, there has been very little experi- 
mental information on how the TCA cycle operates 
in situ and what are the rates of its individual steps. 
The conventional view has been that the cycle always 
begins with the citrate synthase reaction and then 
proceeds until 2 tool of CO 2 are liberated and the 
system re-generates oxaloacetate for the subsequent 
condensation with acetylCoA. It is also widely ac- 
cepted that under a given set of conditions the slow- 
est reaction in the sequence, i.e., that with the largest 
control coefficient, determines the overall rate. This 
general concept neglects the fact that the carbon 
skeletons of certain amino acids enter the TCA cycle 
at points other than the citrate synthase reaction and 
if such an entry bypasses the slowest step, a situation 
may be created in which different portions of the 
cycle can operate at different velocities. 
The first quantitative estimate of flux through the 
TCA cycle in nervous tissue came from computer 
simulation of a model based on the time courses of 
incorporation of 15NH3 and [13C]glucose and 
[~3C]acetate into glucose, glutamine and aspartate 
[40]. The metabolites and pathways were divided 
between a large (presumably neuronal) and a small 
(presumably glial) compartment and the slowest 
(considered then 'rate-controlling') reaction in the 
former was calculated as occurring with a velocity of 
1.25 /xmol/min per g wet weight. The rate of ex- 
change of 2-oxoglutarate and glutamate in the model, 
which represents he aspartate aminotransferase reac- 
tion, was estimated to be 10- to 20-fold greater than 
the net flux through the cycle. More recently, Mason 
et al. [41] used NMR to measure isotopic labelling of 
carbon atoms C4 and C3 of glutamate after an intra- 
venous infusion of [l-~3C]glucose. After fitting the 
results to a mathematical model in which brain was 
treated as a single compartment system, the rate of 
the TCA cycle calculated from labelling of glutamate 
C4 was found to be 1.58 ~mol /min per g wet 
weight, which is not significantly different from that 
derived by the computer simulations discussed above. 
Moreover, the 2-oxoglutarate/glutamate exchange, 
Cytosol Mitochondrion 
~ Aspartate~ f . . .~  Aspartate* ~cis-Aconitate°..~ mat~e~)~ 12;  rate Isocit~ eO Gluta ~Glutama~l\AcetylCoA (~; 
Oxaloacetate ° %Oxaloacetat / - '.e.e 2_Oxoglutarate*~Glutamate *e 
® <®1 ) .  7, ®l.  ], ,~ , )  | Malate , Succinate Glutamine 
Ualate~..~_.~Ualate ° ~""Fumarate ~' ' /  
2-Oxoglutarate ? 2.0xoglutarate 
Malate/Aspartate Shuttle TCA Cycle 
Fig. 1, Pathways of the label transfer from [2Hs]glutamine and [3-J3C]aspartate used to measure flux through the various steps of the 
TCA cycle. * Denotes the ZH label and • the ~3C label. The numbers describe the following: 1, aspartate aminotransferase; 2, 
aspartate/glutamate exchanger; 3, dicarboxylate carrier; 4, malate dehydrogenase; 5, citrate synthase; 6, isocitrate dehydrogenase; 7, 
2-oxoglutarate dehydrogenase; 8, glutaminase. Flux rates are summarized in Table 3. Adapted from Yudkoff et al. [42]. 
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assessed from the difference between the rates of 
isotopic enrichment of glutamate C4 and C3, was 
estimated to be almost 2 orders of magnitude faster. 
Interestingly, the rate of oxygen consumption derived 
on the basis of the measured TCA cycle flux was 
about 4.5 /zmol/min per g, a value very similar to 
that measured in brain by independent methods. 
In synaptosomes the rates of flux through the 
various segments of the TCA cycle have been mea- 
sured with stable isotopes and gas chromatography- 
mass spectrometry technology [42]. Two labelled pre- 
cursor substrates were used: deuterated glutamine and 
[3-13C]aspartate (Fig. 1). The former allowed esti- 
mates of velocities between 2-oxoglutarate and ox- 
aloacetate and the latter, between oxaloacetate and 
2-oxoglutarate. (An underlying assumption in these 
studies, which is amply supported by data in the 
literature, was that the aspartate aminotransferase re- 
action is much faster than the net flux through the 
TCA cycle and hence labelling in aspartate reflects 
that in oxaloacetate and labelling of glutamate corre- 
sponds to that in 2-oxoglutarate.) As seen in Table 3, 
the reactions between oxaloacetate and 2-oxogluta- 
rate are much slower than those between 2-oxogluta- 
rate and oxaloacetate. The slowest overall step is 
located between oxaloacetate and citrate and thus 
involves either the citrate synthase reaction or the 
reaction which supplies acetylCoA to the cycle, i.e., 
that catalyzed by pyruvate dehydrogenase. The veloc- 
ity of this reaction is 0.92 nmol/min per mg protein 
at 28°C, which is about 1/3 of the rate of respiration 
in synaptosomes incubated with glucose at the same 
temperature (Table 1). Thus the relation between 
TCA flux and oxygen consumption i synaptosomes 
is the same as that in whole brain (see above). The 
interesting question as to which of the two enzymes 
controls cycle activity can not be answered on the 
basis of the GC-MS measurements. However, the 
velocity of pyruvate dehydrogenase has been mea- 
sured by independent methods and the values re- 
ported are 2.7-3.5 nmol/min per mg protein at 37°C 
[43,44] and 2 nmol/min per mg protein at 30°C [15]. 
This is about twice the rate of the slowest reaction in 
the TCA cycle. 
The velocity of the portion of the TCA cycle 
between citrate and 2-oxoglutarate is 2.57 nmol/min 
per mg protein (28°C) and probably reflects the rate 
of isocitrate dehydrogenase activity which is likely to 
be slower than that of aconitase. In the segment 
between 2-oxoglutarate and oxaloacetate the reac- 
tions from succinate and malate to oxaloacetate are 
considerably faster than the flux through 2-oxogluta- 
rate dehydrogenase. Interestingly, the velocity of the 
latter, 3.14 nmol/min per mg protein (28°C) in the 
presence of glucose is very close to that of isocitrate 
dehydrogenase and possibly these two calcium-de- 
pendent enzymes operate in situ at similar speeds. 
The velocity of the segment between 2-oxogluta- 
Table 3 
Rates of flux through different segments of the TCA cycle 
Reaction Rate (nmol /min per mg protein) 
A. [2,3,3,4,4- 2Hs]glutamine as precurors 
glutamate (2-oxoglutarate) ~ aspartate (oxaloacetate) 
+ glucose 3.14 + 0.39 
- glucose 4.94 +_ 0.66 
succinate -~ aspartate (oxaloacetate) 
+ glucose 8.21 ± 0.98 
- glucose 8.55 _+ 1.41 
malate --, aspartate (oxaloacetate) 
+ glucose 6.65 _+ 1.50 
- glucose 10.08 _+ 1.80 
B. [3- I¢C]aspartate as precursor 
malate -~ glutamate (2-oxoglutarate) 0.92 ± 0.10 
citrate ~ glutamate (2-oxoglutarate) 2.57 ± 0.23 
Rates of flux through the different segments of the TCA cycle (see Fig. 1 for the outline) were calculated from the isotopic enrichment 
measured with gas chromatography-mass spectrometry in the appropriate metabolites. Values, which were normalized to 100% atom 
percent excess in the various precursors, are taken from Yudkoff et al. [42]. 
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rate and oxaloacetate, as determined by 2-oxogluta- 
rate dehydrogenase activity, is 3-fold faster than the 
overall flux of the TCA cycle in the presence of 
glucose and 5-fold faster in its absence. This means 
that when the necessity arises the pools of oxoacids 
and in particular that of oxaloacetate, which is pre- 
sent at a very low concentration in most cells, can be 
replenished rapidly by metabolism of substrates uch 
as glutamate. The issue which awaits further study is 
whether, and to what extent, any of the fluxes mea- 
sured thus far under resting conditions are modified 
during increased activity (e.g., stimulation of ion 
movements) and what are the factors responsible. 
The rate of synaptosomal metabolism of pyruvate, 
the product of aerobic glucose breakdown, is gener- 
ally considered to be determined by the activity of 
the pyruvate dehydrogenase complex and not pyru- 
vate transport across the mitochondrial membrane. 
The complex contains 3 catalytic (pyruvate dehydro- 
genase, dihydrolipoamide acetyltransferase nd dihy- 
drolipoamide dehydrogenase) and 2 regulatory 
(pyruvate dehydrogenase kinase and pyruvate dehy- 
drogenase phosphatase) proteins [38,45-48]. Pyru- 
vate dehydrogenase kinase converts the complex to 
an inactive phosphorylated form; it requires Mg 2+ 
and is stimulated by NADH, acetylCoA and K + and 
inhibited by NAD, CoA, ADP and Pi. The phos- 
phatase converts the complex to an active non-phos- 
Table 4 
Effect of enhanced ion movements and substrate supply on synaptosomal energy level and rates of energy production 
Condition O 2 uptake Lactate production ATP production 
(nmol/min per mg prot) 
mitochondrial total 
ATP ATP/ADP 
(nmol/mg prot) 
Control 
Effectors of ion movements 
Ouabain 1 mM 
Veratridine 40 p~M, 
Monensin 10 ~M, 
Nigericin 5 /IM, 
5.20±0.22 1.40±0.17 31.2 32.6 3.19±0.00 5.81 ±0.16 
4.26±0.18 0.92±0.04 25.6 26.5 3.13±0.16 4.33±0.21 
5 min 16.1 ± 1.03 8.58 ± 2.47 96.6 105 1.60 ± 0.20 1.44 ± 0.22 
15min 12.3±2.03 10.1 ±4.51 73.9 84.0 1.00±0.23 1.03±0.22 
5min 8.98±0.78 16.8± 1.20 53.9 72.1 1.06±0.16 0.96±0.22 
15 rain 8.57 ± 0.93 9.52 ± 0.41 51.4 60.9 0.78 ± 0.39 0.91 ± 0.45 
5rain 8.24± 1.12 7.89± 1.37 49.4 57.3 0.76±0.12 0.69_+0.04 
15 rain 5.64 ± 0.44 4.23 ± 0.76 33.9 38.1 0.53 ± 0.03 0.52 ± 0.06 
Effectors (~f substrate supply 
Leucine l mM, 5min 6.18±0.28 37.1 3.26±0.37 3.81_+0.22 
15rain 6.18±0.28 2 .07±30 37.1 39.2 3.30±0.12 5.17±0.15 
Alanine 1 mM, 5 min 5.93 _+ 0.24 35.6 3.17 ± 0.11 4.40 ± 0.06 
15rain 5.93_+0.24 2.21 _+0.28 35.6 37.8 3.15±0.30 4.73±0.12 
Glutamine 0.5 raM, 5 min 6.38 ± 0.21 38.3 3.22 _+ 0.11 4.34 ± 0.01 
15 min 6.38 ± 0.21 2.10_+ 0.06 38.3 40.4 3.40 ± 0.05 4.54 ± 0.07 
Rotenone 10/~M, 5 rain 0.26 ± 0.05 1.56 1.37 ± 0.19 1.48 ± 0.26 
15rain 0.26±0.05 15.4±2.31 (12) 1.56 [7.0 1.13±0.08 0.97±0.15 
Glucose 0 raM, 5 min 4.48 ± 0.21 < 0.1 26.9 26.9 1.94 _+ 0.14 3.18 ± 0.52 
15min 4.48+_0.21 <0.1 26.9 26.9 1.97 ± 0.11 3.26 ± 0.21 
+ Glutamine 0.5 mM5 min 5.46 + 0.35 < 0.1 32.8 32.8 2.39 ± 0.21 2.73 ± 0.10 
15min 5.46±0.35 <0.1 32.8 32.8 1.96±0.13 3.38±0.35 
+ Rotenone l0~M,  5min 0.25±0.07 <0.1 1.50 1.5 0.20±0.04 0.41 ±0.12 
15rain 0.25±0.07 <0.1 1.50 1.5 0.23±0.01 0.75±0.17 
All measurements were carried out at 37°C. The rates of lactate production were calculated from the difference in the level of this 
metabolite at time '0' (i.e., after 10 min of preincubation with glucose and calcium) and after 5 or 15 rain of incubation either with 
(experimental) or without (control) the compounds indicated. Glucose was present in all conditions but last three. Nucleotides were 
measured by HPLC on neutralized perchloric acid-extracts of synaptosomes quenched after 5 or 15 min incubation. The rates of ATP 
production were calculated assuming stoichiometric factors of 6 (02 uptake) and 1 (lactate generation), respectively. With ouabain, all 
parameters were the same at 5 and 15 min of incubation. Values are mean ± S.E.M. for 3-8 experiments and are taken from Erecifiska 
and Dagani [15], Erecifiska et al. [146,156] or represent unpublished results. 
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phorylated form with Mg 2+ as an essential co-factor. 
The phosphatase is stimulated by low (micromolar 
and less) concentrations of calcium and spermine and 
is inhibited by NADH. Calcium is usually considered 
to be the key physiological regulator of pyruvate 
dehydrogenase although it is not clear whether this is 
also the case in synaptosomes. Depolarization of 
nerve endings increases the rate of oxygen consump- 
tion, pyruvate decarboxylation a d the active state of 
the enzyme [15,43,44,47,49] but, somewhat confus- 
ingly, these phenomena have been shown to be either 
calcium-dependent (completely, [44]; or incom- 
pletely, [47,49]) or calcium-independent [15]. More- 
over, stimulation of respiration by veratridine or un- 
coupler in glucose-starved, pyruvate-supplemented 
preparations has been found not to require calcium 
[50]. Thus, there is no consistent evidence that the 
cation is necessary for activity-induced changes in 
synaptosomal metabolism of pyruvate and it is con- 
ceivable that flux through the enzyme is regulated to 
a large extent by changes in ATP /ADP and 
NADH/NAD [47]. 
There is almost no information about the 
metabolism of fatty acids by synaptosomes. The evi- 
dence that in vivo acetate is handled predominantly 
by the 'small' (i.e., glial) compartment seems to 
suggest that fats are not an important source of 
energy in nerve endings. 
3.4. Role of amino acids" in energy metabolism 
The major potential substrate amino acids are glu- 
tamine, alanine, leucine (and other branched chain 
amino acids) and GABA. Glutamine, one of the most 
abundant plasma and brain amino acids, cannot be 
utilized directly as a fuel but has to be converted to 
glutamate by a phosphate-dependent glu aminase [51 ] 
(and for review Ref. [52]). Its activity in synapto- 
somes is high [53] and glutamine has long been 
considered a 'major substrate for nerve endings' [54]. 
Since glutamine is produced in brain only in astro- 
cytes and metabolized predominantly by nerve cells, 
a glutamine/glutamate cycle [55] has been invoked 
to account for the situation. 
The entry of amino acids into the TCA cycle 
involves two types of reactions. The first is repre- 
sented by glutamate dehydrogenase, which yields 
2-oxoglutarate and NADH (as well as ammonia), and 
thus produces reducing equivalents and leads to a net 
increase in the pool of Krebs-cycle intermediates. In 
synaptosomes, when glucose is present and the inter- 
nal level of glutamate is maintained by addition, the 
rate of the glutamate dehydrogenase reaction is 
slightly less than 0.3 nmol /min per mg protein at 
28°C (about 8 nmol /30 min per mg protein of am- 
monia produced or glutamate consumed, [56]) i.e., 
considerably slower than the net flux through the 
TCA cycle. (The rate of glutamate formation from 5 
mM ammonia is about 0.2 nmol /min per mg protein; 
[57].) While it appears that this velocity can be 
enhanced somewhat in the absence of glucose [56], it 
remains to be established whether the rise in [ADP] 
which occurs under such conditions (Table 4) acti- 
vates glutamate dehydrogenase and hence increases 
the rate of glutamate breakdown. 
The second type of reaction involves the participa- 
tion of transaminases. With the recent application of 
JSN-labelled amino acids and gas chromatography- 
mass spectrometry, several strides have been made in 
our understanding of the role of transamination i
synaptosomal metabolism of energy substrates. The 
three enzymes, aspartate-, alanine- and branched chain 
amino acid transaminases, which have been examined 
in some detail, catalyze, respectively, the following 
reactions: 
glutamate + oxaloacetate 
,--, aspartate + 2-oxoglutarate 
alanine + 2-oxoglutarate ~ pyruvate + glutamate 
branched chain amino acid + 2-oxoglutarate 
branched chain keto acid + glutamate 
All three proteins reversibly transfer nitrogen be- 
tween amino acids and cognate keto acids but each 
seems to perform a somewhat different function. By 
far the most important of the three is the aspartate 
aminotransferase, an enzyme with a very high total 
activity: 1214 nmol /min per mg protein in synaptic 
mitochondria nd 316 nmol /min per mg protein in 
synaptosol  [58]. Using [15N]aspartate and 
[~SN]glutamate, it has been shown that aspartate 
aminotransferase i  near equilibrium in nerve endings 
[6], a situation similar to that in whole brain [59,60]. 
Although the in situ unidirectional rates were calcu- 
lated to be in the range 4-6 nmol /min per mg 
protein and about equal in both directions [6], this 
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value is a substantial underestimate for at least two 
reasons: (1) the back reactions are very fast and 
hence the estimated unidirectional ~SN transfer is 
always considerably slower than the true velocity; 
and (2) isotopic enrichment taken at the earliest ime 
point of measurement (2 min of incubation) is overes- 
timated. The combined influence of these two factors 
is likely to increase the bidirectional rates of nitrogen 
transfer between aspartate and glutamate by at least 
2- to 4-fold above the calculated rate, i.e., to a value 
of 10-20 nmol/min per mg protein, which is an 
order of magnitude, or more, faster than the measured 
slowest reaction in the TCA cycle (Table 3). (Be- 
cause the unidirectional rates are identical, within the 
limits of experimental error, the net flux is very low.) 
The high activity of aspartate aminotransferase, its
ready reversibility, low net flux and the occurrence of 
aspartate and glutamate in large concentrations in the 
nerve endings (and brain) suggest hat the enzyme 
serves as a buffer to maintain a proper balance of the 
intermediates in the TCA cycle and in particular the 
levels of the oxo acids, 2-oxoglutarate and oxaloac- 
etate. This postulate is supported by the finding that 
the flux through the segment of the cycle between 
2-oxoglutarate and oxaloacetate is 3- to 5-fold faster 
than the overall rate. It may be important to note that, 
although the in situ activity of aspartate aminotrans- 
ferase is high in relation to those of many other 
catalytic proteins, it is only a few percent of the total 
capacity of the enzyme measured in broken synapto- 
somal preparation or its subfractions [58]. 
Aspartate aminotransferase may serve yet another 
function. When glutamate reacts with oxaloacetate, 
2-oxoglutarate is produced which can then be oxi- 
dized stepwise to regenerate oxaloacetate and con- 
comitantly produce ATP. The balance of this 'sub- 
cycle' of the TCA cycle is utilization of glutamate 
and formation of aspartate plus energy. Such a se- 
quence of reactions obviously does operate in the 
absence of carbohydrate substrates when it can sus- 
tain ATP-requiring processes for a while. Its function 
is eventually curtailed by accumulation of aspartate 
which brings transamination to a state of equilibrium 
when utilization of glutamate qualizes with its for- 
mation by the reverse reaction. 
Consumption of alanine in the alanine aminotrans- 
ferase reaction leads to the formation of glutamate 
and 'replacement' of 2-oxoglutarate with pyruvate. In 
theory, if this reaction was fast enough or if other 
sources were limited, it could be of importance in 
generating lutamate. This latter is, on the one hand, 
a key excitatory neurotransmitter and on the other, an 
energy substrate which can be metabolized through 
either the glutamate dehydrogenase or aspartate 
aminotransferase reactions. Moreover, from the ener- 
getic viewpoint, combustion of pyruvate in the TCA 
cycle produces more ATP molecules than can be 
derived from 2-oxoglutarate oxidation. However, in 
synaptosomes the flux from [15N]alanine to 
[ISN]glutamate at 28°C is only 0.09 nmol/min per 
mg protein and although it can be increased to 0.26 
nmol/min per mg protein by addition of 0.5 mM 
2-oxoglutarate [61], this is still over an order of 
magnitude slower than the rate of glutaminase activ- 
ity (> 4 nmol/min per mg prot; [62,63]). Thus ala- 
nine, seems not to be efficient either as an energy 
substrate or a precursor of glutamate. Interestingly, 
the rate of alanine formation from glutamate is con- 
siderably faster, 0.74 without and 1.85 nmol/min per 
mg protein (28°C) with 5 mM pyruvate [61]. This 
suggests that the alanine aminotransaminase reaction 
in synaptosomes i  poised in such a manner that it 
serves to generate alanine, rather than to consume it. 
Neurons contain a transaminase which catalyzes 
nitrogen transfer between glutamate and branched 
chain amino acids and among branched chain amino 
acids themselves (hence termed branched chain 
aminotransferase). In synaptosomes, the enzyme is 
distributed about evenly between the soluble and 
mitochondrial fractions. The flux of nitrogen from 
labelled leucine to glutamate is, in the presence and 
absence of 0.5 mM 2-oxoglutarate, 0.30 and 0.20 
nmol/min per mg prot, respectively (28°C), while 
that from labelled glutamine to leucine, with 25 /_tM 
c~-ketoisocaproate in the medium, is 1.03 nmol/min 
per mg protein [64]. Similar values are seen for the 
rates of N transfer between valine and glutamate. In 
cultured astrocytes, leucine and valine are rapidly 
deaminated and the corresponding ketoacids are re- 
leased into the external environment [65,66]. It has 
been proposed, therefore [64], that neurons (and their 
endings) take up branched chain ketoacids, transami- 
nate them with glutamate and re-generate the parent 
amino acids which, in turn, are released to the exter- 
nal environment. This situation would create a 
branched chain amino acid/glutamate cycle analo- 
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gous to that proposed for glutamine/glutamate [55]. 
In the presence of high concentrations of branched 
chain ketoacids, the former cycle would 'buffer' the 
content of intrasynaptosomal glutamate. 
Utilization of GABA (GABA shunt) also proceeds 
via a transamination reaction, but instead of an 
oxoacid it produces succinate semialdehyde (while 
nitrogen is transferred in glutamate) which enters the 
TCA cycle as succinate. The overall rate of the shunt 
is considered to be determined by the activity of 
glutamic acid decarboxylase, the enzyme responsible 
for GABA formation, which is regulated in a com- 
plex manner [67]. The initial rate of formation of the 
amino acid from glutamate generated from 
[~SN]glutamine was estimated to be about 0.1 
nmol/min per mg protein at 28°C [62]. This is likely 
to be an underestimate because of the subsequent 
metabolism of GABA by GABA-transaminase. How- 
ever, measurements of shunt enzyme activities in 
various fractions of the brain [68] showed that synap- 
tosomal GABA-T is considerably ess active than that 
in perikaryal mitochondria. This indicates that in 
synaptosomes, the primary role of GABA is that of a 
transmitter and not a fuel. 
A question which has attracted attention recently is 
whether nerve terminals and/or neurons are com- 
pletely self-sufficient in terms of energy substrates 
they generate from external glucose or whether they 
rely, in part, on some other source. It is well known 
that glutamate is re-cycled between eurons and as- 
trocytes via the 'glutamate/glutamine cycle' [55]. 
However, it has been shown recently that astrocytes 
in culture release several metabolites including lac- 
tate [69], intermediates of the tricarboxylic acid cycle 
[70,71] and ketone bodies [65,66] to the external 
environment. Conversely, synaptosomes, in contrast 
to a number of intact cells, take up 2-oxoglutarate 
and malate rapidly by high-affinity systems [72,73]. It 
is not known whether the same obtains in brain in 
vivo, although in mammalian retina lactate released 
from glial cells has been shown to be metabolized by 
photoreceptor neurons [74]. However, neurons and 
nerve endings do not possess pyruvate carboxylase 
[75] and cannot fix CO 2 via this reaction. Thus it is 
not inconceivable that where there are large move- 
ments of glutamate and other amino acid transmitters 
into the extracellular medium, some of the carbon 
skeleton is returned from astrocytes to the terminals 
in the form of lactate/pyruvate and/or intermediates 
of the TCA cycle and not exclusively as glutamine. 
3.5. Transfer of reducing equivalents from the cytosol 
to the mitochondrion 
It is generally believed [76] that in brain, cytosolic 
reducing equivalents (NADH 2) are transferred into 
the mitochondrion on the glycerol-3-phosphate shut- 
tle. This textbook statement relies on the finding that 
nervous tissue contains two glycerol-3-phosphate de-
hydrogenases, one of which is cytosolic and utilizes 
NAD-- as a coenzyme, while the other is located in 
the mitochondrial membrane and is a flavoprotein 
[77]. Thus the NADH 2 generated uring glycolysis 
combines with dihydroxyacetone phosphate and the 
reduced product, glycerol-3-phosphate, is then oxi- 
dized by the mitochondrial enzyme to yield FADH 2. 
Because the latter dehydrogenase d livers electrons 
to complex III and not I, only 2 mol of ATP are 
generated from the original mole of NADH 2. There 
is no information on how active, or quantitatively 
important, his pathway is in synaptosomes. 
However, brain contains yet another means of 
oxidizing cytosolic NADH 2, the malate/aspartate 
shuttle [78-80]. This involves the combined opera- 
tion of cytosolic and mitochondrial spartate amino- 
transferases and malate dehydrogenases and the in- 
flux of malate to (balanced by 2-oxoglutarate coming 
out), and efflux of aspartate from (balanced by gluta- 
mate going in), the organelles. The importance of this 
pathway is underscored by the observations that inhi- 
bition of transaminases in brain slices [81] and 
synaptosomes [58,82] decreases oxygen consumption 
and lowers the energy level ([ATP]/[ADP]). In iso- 
lated 'free' brain mitochondria the activity of the 
'reconstituted' malate/aspartate shuttle has been 
found to be 16 nmol NADH oxidized/min per mg 
protein at 25°C which is 5- to 7-fold slower than the 
rates of oxygen consumption with various respiratory 
substrates [58]. 
The rate at which the malate/aspartate shuttle 
operates in synaptosomes in situ has not been mea- 
sured but some information can be derived from 
ind i rect  exper iments .  In s tudies  with 
[2,3,3,4,4,2Hs]glutamine, it was noticed that [3- 
2H]malate, which can only be formed in the cytosol 
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(i.e., through the shuttle), was labelled as highly as 
the mitochondrially-generated [3-2H]aspartate [42]. 
Similarly, in experiments with [3-J3C]aspartate, the 
isotopic enrichment in malate was even at the earliest 
time point as high as that in its precursor [42]. Since 
external aspartate enters the mitochondrion asmalate, 
this result means that the activity of cytosolic aspar- 
tate aminotransferase and malate dehydrogenase is 
high. On the other hand, the fact that labelling of 
citrate from [3-~3C]aspartate occurred alter a lag of 
minutes indicates that mitochondrial spartate amino- 
transferase, which equilibrates labelled oxaloacetate 
with a relatively large pool of aspartate, is much 
faster than the transport of malate (2-oxoglutarate) 
across the mitochondrial membrane. All these results 
taken together suggest hat the slowest step in the 
malate/aspartate shuttle is faster than the net flux 
through the TCA cycle but considerably slower than 
aspartate aminotransferase activity. Such a relation- 
ship ensures that there is no substantial ccumulation 
of lactate under 'normal', aerobic conditions when 
energy demand is moderate. However, it has been 
shown (e.g., Refs. [59,83,84]) that large increases in 
ATP demand, such as during enhanced activity or 
seizures, are accompanied by pronounced early rises 
in lactate concentration i the CNS. This suggests 
that transfer of reducing equivalents into the mito- 
chondria is not increased by the same factor that 
glycolysis is activated and that cytosolic NAD is 
regenerated, to a large extent, through the lactate 
dehydrogenase reaction. An ensuing rise in the redox 
state (NADHz/NAD +) diverts the cytosolic pym- 
vate to lactate and decreases the availability of pyru- 
vate to the respiratory chain. It should be kept in 
mind that glycolysis and the malate/aspartate shuttle 
are controlled in different ways. With the former, 
allosteric effectors of phosphofructokinase cooperate 
in producing large, rapid increases in the activity of 
the enzyme, and hence of the whole pathway. By 
contrast, flux through the shuttle is governed by 
activity of the enzymes, as well as by the rate of 
metabolite transport across the membrane. Moreover, 
rates at which the various contributing proteins oper- 
ate may also be dependent on the concentrations of
their substrates, such as the oxoacids, which are 
generally low and may not be increased substantially 
during periods of intense neuronal activity. A combi- 
nation of these events results in a large accumulation 
of lactate which can be accompanied by a smaller 
than expected rise in respiration. 
3.6. Mitochondrial respiratory chain 
The synaptosomal mitochondrial respiratory chain, 
which is responsible for oxidation of reducing equiv- 
alents generated in the TCA cycle, has properties 
identical to those of its counterparts in all mammalian 
cells: it is activated by increased substrate input 
([NADH2]/[NAD+]) and lowered energy level 
([ATP]/[ADP] [Pi] or equivalent) [85-89]. Neither 
sodium, potassium nor calcium ions seem to have any 
direct effect on the respiratory chain complexes. 
However, respiration of intact synaptosomes should 
be stimulated by calcium via its action on calcium- 
dependent dehydrogenases of the TCA cycle [38,90]. 
The predicted ecrease in oxygen uptake is indeed 
observed in synaptosomes depleted of Ca 2 + but incu- 
bated in the presence of high Mg 2+ [15]. In other 
studies, elimination of calcium and addition of EDTA 
without addition of high magnesium, stimulated res- 
piration [34,91] which suggests that withdrawal of 
this divalent cation exerts some other, and less spe- 
cific, effects. 
The mitochondrial respiratory chain is sensitive to 
changes in the concentration of H + with acidosis 
reducing respiration in isolated mitochondria and cell 
suspensions [92-96]. Firstly, protons are a compo- 
nent of the proton motive force, the intermediate in
ATP synthesis. Secondly, some of the mitochondrial 
complexes, and in particular the NADH dehydroge- 
nase have been shown to be inhibited by H + [97]. 
Consistent with the latter effect, synaptosomal respi- 
ration has been found to decrease at acidic pH values 
{91]. 
3.7. Synaptosomal energy ler, el in relation to 
metabolic substrates 
Synaptosomes incubated with glucose derive 96% 
of their energy from mitochondrial oxidative phos- 
phorylation (Table 4; [34,82,98]) and generate an 
[ATP]/[ADP] of about 6 (Table 4; [8,9]). Addition of 
glutamine, leucine or alanine increases 0 2 consump- 
tion by 10-15% and lactate generation by 40-60% 
(Table 4). The increases in glycolysis and respiration 
are eliminated by ouabain, suggesting that activation 
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of energy production is a consequence of stimulation 
of the Na/K  pump by sodium ions which enter 
synaptosomes on the Na/amino acid co-transporters 
[61,63,64]. Consistent with this postulate is a statisti- 
cally significant fall in the [ATP]/[ADP] (Table 4). 
(The decrease in the [ATP]/[ADP] seen with leucine 
is only transient most likely because activation of the 
glutamate dehydrogenase by this amino acid stimu- 
lates oxidative deamination of glutamate thereby in- 
creasing production, and consequently, the concentra- 
tion of 2-oxoglutarate.) Such an observation means 
that Na+-linked transport contributes a measurable 
amount o overall ATP usage in nerve endings. This 
may constitute an additional energy drain during 
recovery from ischemia when external levels of amino 
acids are likely to be high. 
Mitochondrial poisons or lack of oxygen 
(anaerobiosis) block the activity of the mitochondrial 
respiratory chain and, if glucose is present, simulta- 
neously activate glycolysis. For example rotenone, an 
inhibitor of the mitochondrial site I enhances lactate 
synthesis 10-fold in synaptosomes (Table 4; [34,99]). 
The underlying mechanism is via activation of the 
rate controlling enzymes, in particular phosphofruc- 
tokinase, by decreasing ATP and increasing ADP, 
AMP and Pi. However, even maximally stimulated 
glycolysis can provide only about 10% of the energy 
that is generated through aerobic metabolism in non- 
stimulated synaptosomes. Consequently, the 
[ATP]/[ADP] declines within 2-5 rain to 1.3-1.7 
(Table 4; [100]), although thereafter it remains at this 
level during 30 min subsequent incubation. Addition 
of glutamine/glutamate to rotenone-inhibited 
synaptosomes incubated with glucose, and either with 
or without pyruvate, does not raise the energy state. 
This suggests that succinylCoA formation is not very 
prominent probably due to low activities of alanine 
aminotransferase and/or fumarate reductase in brain 
[101,102]. 
Elimination of glucose decreases respiration in 
synaptosomes by 20-25% (Table 4). Although this 
seems to be a small reduction, it substantially de- 
creases the nucleotide ratio (Table 4; [8]) and indi- 
cates that, at least in the nerve endings, endogenous 
substrates in the absence of glucose cannot maintain 
a high energy state. Somewhat surprisingly, glu- 
tamine which is an effective precursor of glutamate 
as a respiratory substrate, is unable to prevent (or 
ameliorate) this decline, a situation different from 
that in cultured astrocytes [103]. Without glucose and 
with rotenone present, i.e., when neither glycolysis 
nor oxidative phosphorylation are operative, the 
[ATP]/[ADP] declines within a few minutes to 0.5 or 
less (Table 4; [100]). 
In conclusion, synaptosomes derive their energy 
predominantly through oxidative metabolism, with 
only a minor contribution from glycolysis. In the 
absence of oxygen, [ATP] falls rapidly to a very low 
value. The major respiratory substrate is pyruvate 
(derived from glucose) which is metabolized to CO 2 
and water in the TCA; the slowest (i.e., rate control- 
ling) step of the latter seems to be the citrate synthase 
reaction. Several amino acids can produce the inter- 
mediates of the TCA cycle, although none, in the 
absence of glucose, can maintain an unaltered synap- 
tosomal content of ATP. The most important function 
of the very active aspartate aminotransferase reaction 
is to serve as a 'buffer' which ensures a proper 
balance between 2-oxoglutarate and oxaloacetate. 
4. Synaptosomal energy metabolism in relation to 
ion movements 
4.1. Energy consuming ion moL'ements 
The main function of synapses, the transmission of 
information from one neuron to another, is accom- 
plished by moving ions down their concentration 
gradients. For this to happen, the participating ions 
must be maintained in electrochemical disequilibrium 
across the plasma membrane, a condition which has 
to be rapidly reinstated before a new functional cycle 
can occur. Maintenance and restitution of disequilib- 
ria require input of energy, therefore a large portion 
of ATP generated in the nerve endings is used to 
support ion movements. The key enzyme involved in 
this activity is the Na+/K + ATPase whose density 
over the plasma membrane of the synaptic area in 
brain is very high, as demonstrated by histochemical 
staining [104]. 
The ouabain-sensitive Na+/K + pump extrudes 3 
equivalents of sodium and brings in 2 equivalents of 
potassium against their concentration gradients per 
one mol of ATP hydrolyzed. In a frozen/thawed 
synaptosomal preparation, the maximal activity of the 
26 M. Erecifiska et al. / Biochimica et Biophysica Acta 1277 (1996) 13-34 
Na-dependent ATPase is 160-200 nmol/min per mg 
protein at 37°C [105] and it is somewhat higher in the 
membrane fraction (260 nmol/min per mg protein, 
[106]). Non-stimulated synaptosomes accumulate 5
mM 86rubidium at a rate of 9.8 nmol/min per mg 
protein at 30°C (or about 18 nmol/min per mg 
protein at 37°C; [15]), which is 8-12% of this maxi- 
mal activity. The decrease in oxygen uptake caused 
by ouabain gives a Rb/O 2 of about 12 and thus a 
calculated Rb/ATP of 2, consistent with the known 
stoichiometry of the pump. 
The K m of the Na+/K + pump for potassium in 
broken synaptosomes is 0.65 mM [105] and for potas- 
sium uptake into intact preparations, 0.47 mM [107], 
which agrees well with the ECs0 value for the K+-de - 
pendent stimulation of oxygen uptake and lactate 
synthesis in the intact preparation (0.7-1.5 mM; [15]). 
The K m for Na is considerably higher and values 
reported vary greatly (10-20 mM [105,108]; 80 mM 
[106]); the affinity for the cation may depend on both 
isozyme type and environment of the enzyme, with 
the apparent dissociation constant being larger in 
synaptosomes than in their membranes [108]. There 
are two binding sites for ATP, a catalytic (K m of 
about l0 /zM; [109]) and a regulatory one (K m > 0.5 
raM; [109]). The high K m for ATP on the regulatory 
sites indicates that the concentration of ATP may, 
under some conditions, become an important factor in 
determining the Na pump activity. Consistent with 
this supposition is the observation that addition of 1 
mM amytal, which decreases synaptosomal [ATP] by 
about 30%, significantly reduces the rate of ouabain- 
sensitive 86Rb uptake [15]. The effectors of the pump 
which may be important in short-term regulation of 
the activity of the enzyme are protons, which are 
inhibitory [110], and calcium which has a similar 
influence albeit at high concentrations ([111,112] but 
see Ref. [113] to the contrary). 
Synaptosomes also maintain a large electrochemi- 
cal gradient for calcium. Two mechanisms extrude 
the cation to the external environment: he calcium 
pump and the Na+/Ca 2+ exchanger. The former 
moves calcium out (in exchange for H + coming in) 
and is linked directly to ATP hydrolysis; it functions 
mainly under low calcium loads. The exchanger 
transports 3 equivalents of Na + into, against 1 equiv- 
alent of Ca 2+ leaving the synaptosome and is a high 
capacity system which operates predominantly under 
large calcium loads. It utilizes the Na + gradient as 
the source of energy and is thus linked to ATP 
utilization indirectly via the action of the Na+/K + 
pump. Because the exchanger moves 3 Na + per cycle 
while the pump extrudes the same number of sodium 
equivalents per tool of ATP, the final cost of calcium 
extrusion via this pathway is 1 equivalent per 1 tool 
of ATP hydrolyzed. 
The K m of the Ca pump for calcium is 0.2-0.5 
/~M [114-118] and that for ATP is in the same range 
of concentrations [ 116-118]. The maximal velocity 
measured as the CaZ+/Mg 2+ ATPase activity is 
about 6 nmol/min per mg protein at 37°C in whole 
synaptosomes [116] and 24-33 nmol/min per mg 
protein in synaptosomal membranes [116,118] while 
the rate of ATP-dependent calcium uptake into 
synaptic plasma membrane vesicles is 2.2 nmol/min 
per mg protein at 22°C [117]. The Ca2+/Na + ex- 
changer transports calcium with a high (0.5 /xM) and 
low (increased accumulation of calcium occurs to 3 
raM) affinity [117]. The rate of calcium extrusion by 
the pump in whole calcium-loaded synaptosomes has 
been estimated to be 0.6 to 1.5 nmol/min mg protein 
at 30°C [119,120] and that by the Na+/Ca 2+ ex- 
changer, 6.6-9.1 nmol/min per mg protein [119,120]. 
It is not clear whether these estimates represent maxi- 
mal velocities of the two systems or the rate at which 
they operated under a particular set of conditions. 
The flux through the exchanger will depend on the 
calcium and sodium gradients, and the membrane 
electrical potential, and could go to zero and even 
reverse when the ionic balances change. It should be 
pointed out that during stimulated release of neuro- 
transmitters, uch as occurs in enhanced neuronal 
activity, the intracellular concentrations of calcium in 
some domains of presynaptic terminals rises to as 
high as 200-300 #M [121]. This large increase in 
[Ca2+]i would be expected to activate both the pump 
and the Na+/Ca 2+ exchanger. 
The rate of calcium uptake by non-stimulated 
synaptosomes is 0.5-1.6 nmol/min per mg protein at 
30-37°C [4,13,122-124], which corresponds to the 
same rate of ATP usage; this small figure would have 
a negligible effect on the overall rate of energy 
production. Under stimulated conditions, influx of 
Ca 2+ can  increase 3- to 6-fold [122,124,125] and thus 
augment he rate of ATP hydrolysis to 3 to 10 
nmol/min per mg protein. However, most of the 
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calcium entering nerve endings seems to be buffered 
by internal mechanisms [126]. 
4.2. Decreased energy generation and maintenance 
of  ion moL, ements and gradients 
Removal of glucose from the external environment 
of synaptosomes increases both the [Ca 2 + ]i [ 127,128] 
and the rate of calcium transport across the synapto- 
somal membrane [128]; however, there is no de- 
tectable change in [K+]~ even after 60 rain of 
aglycemic incubation [129]. Assuming that the tech- 
nique used to measure potassium was sensitive nough 
to identify small changes in its internal concentration, 
this raises the question of mechanism(s) responsible 
for changes in calcium handling. The apparent lack of 
depolarization (potassium loss) seems to eliminate 
the simplest explanation, the opening of the voltage- 
dependent channels. Another possibility, a release 
from endoplasmic reticulum stores [130] caused by 
an aglycemic decrease in free energy change for ATP 
hydrolysis (Table 4) is inconsistent with the reported 
enhancement of influx. Notwithstanding, the results 
suggest hat glucose is very important in maintaining 
calcium homeostasis n synaptosomes. 
Another, somewhat paradoxical finding is that 
anoxia decreases calcium uptake by synaptosomes 
under basal conditions and after stimulation with 
either high [KCI] or veratridine [122,124,128]. A
similar inhibition by anoxia of veratridine-enhanced 
(but not basal) transport has been reported in hip- 
pocampal slices [131]. These results are difficult to 
reconcile with the observations that anaerobiosis not 
only causes a release of potassium from synapto- 
somes but also potentiates efflux induced by veratri- 
dine [132] and thus results in greater depolarization 
of the plasma membrane. It has been proposed that 
lactate, which mimics the effect of anoxia on calcium 
movements, blocks calcium channels directly [133]. 
However, inhibition of the veratridine-induced rise in 
[Ca2+] i requires 32 mM lactate, a concentration un- 
likely to be attained during anaerobic incubations of 
nerve endings with glucose. An alternate mechanism 
invokes inhibition of mitochondrial calcium influx 
brought about by a decline in the mitochondrial 
membrane potential [134]. Whatever the merits of the 
individual hypotheses, neither explains the finding 
that rotenone or KCN, which like anoxia inhibit the 
Table 5 
Changes in intrasynaptosomal concentrations of potassium and 
calcium caused by addition of ionophores orinhibitors of energy 
production 
Conditions [ K+ ]i (raM) [ Ca2+ ]i (nM) 
None 52-60 256 +_ 36 
Veratridine. 50 #M 35 ± 0.3 563 _+ 48 
Monensin. 10 /xM 15-18 765 ± 230 
Nigericim 5 /xM 10-12 1187_+ 105 
Amytal, 2mM 48.7 + 7.1 ~L n.ch. 
Amytal, 2mM. 0 glucose 36.5 + 4.3 ~' 512 b 
KCI, 40 mM 395 ± 12 
Numbers represent either ranges or means_+S.D. Results are 
taken from Dagani and Erecifiska [129], Erecifiska nd Dagani 
[15], Erecifiska et al. [146,156] and Dagani et al. [135]. " Values 
after 30 rain incubation, b Value after 10 min incubation with 10 
/xM rotenone instead of amytal, n.ch. no change after 10 min 
incubation. For values for [Ca ~-* ]i with KCI or veratridine from 
other laboratories (see Ashley et al. [160], Richards et al. [159], 
Hansford and Castro [47], Kauppinen et al. [100]). 
function of the respiratory chain, either do not change 
or increase the concentration of internal calcium 
[100,135,136]. 
Anoxia and/or inhibition of the mitochondrial 
respiratory chain cause a release of internal potas- 
sium and decrease synaptosomal plasma membrane 
potential ([122,129,132,137]; Table 5). The rate of 
K + leakage in anaerobiosis and with glucose present 
is 4.5-10.1 nmol/min per mg protein at 25°C; this 
velocity is reduced below pH 6.5 and at calcium 
concentrations > 2.5 mM [132]. 
Combined absence of glucose (or inhibition of 
glycolysis) and anoxia (or inhibition of the mitochon- 
drial respiratory chain), which mimic the situation of 
in vivo ischemia, led to an increase both in the rate of 
influx of calcium and its concentration inside 
synaptosomes [100,127,128,135]. Interestingly, in in 
vitro models of synaptosomal ischemia [Ca2+]i rises 
only to a level of 1 /xM or less (Table 5), whereas 
increases in neurons in vivo under similar conditions 
are 10- to 100-fold greater [138,139]. The anaerobic 
rate of K + release is twice as fast in synaptosomes 
supplied with lactate/pyruvate as in those with glu- 
cose [132]. Consistent with these differences in rates, 
the amount of potassium retained by nerve endings is 
markedly higher when glucose is present [135]. This 
points to the importance of glycolytically generated 
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Table 6 
The dependence of ATP and ATP/ADP on calcium in synaptosomes 
Condition ATP ATP/ADP 
5 min 15 min 5 min 
(nmol /mg prot) 
15 min 
Ca 2 + 
+Glucose 3.40 + 0.05 3.19 _+ 0.14 5.94 +_ 0.18 5.52 + 0.22 
KCI 2.10 + 0.08 1.96 + 0.03 3.07 + 0.05 2.98 ___ 0.19 
Rotenone 1.36 ± 0.10 0.95 + 0.04 1.44 ± 0.10 1.23 _ 0.06 
KCI + rotenone 0.94 +_ 0.03 0.78 _+ 0.03 1.07 ± 0.04 1.06 _+ 0.01 
-G lucose 1.94 _+ 0.14 1.87 _+ 0.11 3.18 _+ 0.26 3.26 _+ 0.21 
KCI 0.85 _+ 0.11 0.69 ± 0.09 1.87 ± 0.11 1.79 ± 0.09 
Rotenone 0.08 _+ 0.01 0.06 _+ 0.00 0.35 ± 0.03 0.35 _+ 0.02 
KCI + rotenone 0.08 ± 0.02 0.07 _+ 0.02 0.31 ± 0.05 0.33 _+ 0.08 
Mg 2+ 
+Glucose 3.33 _+ 0.07 3.25 _+ 0.21 5.24 _+ 0.28 5.03 _+ 0.32 
KC1 2.46 _+ 0.16 2.45 _+ 0.04 4.44 ± 0.16 4.72 ± 0.15 
Rotenone 1.88 _+ 0.05 1.23 _+ 0.13 1.78 ± 0.01 1.25 +_ 0.09 
KC1 + rotenone 1.44 _+ 0.04 1.07 _+ 0.04 1.59 ± 0.05 1.34 ± 0.05 
-G lucose 2.54 _+ 0.09 2.10 ± 0.09 3.96 ± 0.35 2.98 ± 0.42 
KCI 1.18 + 0.12 1.00 ± 0.10 3.55 ± 0.20 3.40 _+ 0.31 
Rotenone 0.12 _+ 0.01 0.07 _+ 0.01 0.39 ± 0.03 0.32 ± 0.02 
KCI + rotenone 0.10 ± 0.03 0.09 ± 0.02 0.36 ± 0.06 0.37 ± 0.03 
ATP and ADP were measured by HPLC (Erecifiska and Nelson [9]) in synaptosomes incubated for 5 or 15 min under the conditions 
indicated (with or without 10 mM glucose and either with 1.27 mM CaC12 or 10 mM MgCI~_). KC1 was added at 50 mM and rotenone at 
10 /xM. Values represent means _+ S.E.M. for 3-7 experiments. 
ATP in maintaining the function of the Na/K  pump 
in these terminals. 
4.3. Effect of calcium on ATP and ATP /ADP 
Calcium is a key intracellular cation, the controller 
of a number of important activities and probably the 
foremost second messenger. Because [Ca  2+] inside 
neurons and their terminals is normally very low, but 
can increase rapidly, the influence of the cation on 
[ATP] and [ATP]/[ADP] is of great interest. Yet, 
surprisingly there is no information in the literature to 
this effect. For this reason we have made the appro- 
priate measurements and compiled them (Table 6) to 
be used as a reference. The results show very clearly 
that under most conditions (which include glucose 
withdrawal, depolarization with KC1, inhibition of the 
respiratory chain by rotenone and depolarization con- 
comitant with inhibition of oxidative phosphoryla- 
tion), synaptosomal content of ATP, as well as 
[ATP]/[ADP], are lower with calcium present. This 
suggests that either elimination of calcium from the 
cytosol or stimulation by calcium of an energy-re- 
quiring reaction, or both, consume measurable amount 
of energy and cause a reduction in synaptosomal 
energy state (ATP/ADP). 
4.4. Decreased energy generation and neurotrans- 
mitter elease 
There are two mechanisms that lead to transmitter 
release from nerve terminals: exocytosis, whose hall- 
mark is calcium dependence, and carrier-mediated 
effiux, which occurs when driving forces for uptake 
fall below the transmitter electrochemical gradient 
[140]. Because xocytosis requires ATP [ 141] in addi- 
tion to calcium, a limitation in energy production will 
exert two opposing effects on calcium-dependent re-
lease: stimulation due to a rise in [Ca2+]± and inhibi- 
tion caused by ATP depletion. On the other hand, 
carrier-mediated, calcium-independent efflux should 
increase when intrasynaptosomal energy level falls. 
The decrease in exocytotic release and an enhance- 
ment of carrier-mediated fflux of glutamate with a 
reduction in [ATP] are well-known ([100,142] and for 
review, Refs. [143,144]). However, whether the same 
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pertains to other neurotransmitters, such as GABA or 
catecholamines, has not been determined, although 
increased leakage which accompanies inhibition of 
mitochondrial energy generation has been observed 
previously [129,145]. To fill this gap in our knowl- 
edge we have measured patterns of release of GABA 
and aspartate, and a catecholamine dopamine, under a 
variety of conditions and compared them with those 
for glutamate. The question of the dependence on 
[ATP] could be approached more easily because the 
concentration of the nucleotide in a given situation 
was measured in parallel experiments (Table 6). 
These results are summarized in Table 7. The 
following conclusions can be drawn. (1) Calcium-in- 
dependent effiux of neurotransmitters markedly in- 
creases with a fall in [ATP]; since the reduction in 
ATP under various pathological conditions is a time- 
dependent phenomenon, non-exocytotic release accel- 
erates with time. A rise in [Na+]j is probably the key 
factor responsible for stimulation of the latter events. 
In addition, the collapse of the sodium gradient and 
membrane depolarization decrease the driving forces 
for transmitter uptake with consequent inhibition of 
influx and accumulation of amino acids in the exter- 
nal environment. (2) Calcium-dependent, exocytotic 
component of glutamate, aspartate and dopamine re- 
lease exhibits a behaviour opposite to that of the 
carrier-mediated effiux; it decreases with a fall in 
[ATP] and with time. Consequently, at longer periods 
of energy deprivation (< 5 min) only non-vesicular 
release occurs. (3) Exocytotic release of GABA does 
not seem to be ATP-dependent. Reasons for this are 
not known but this potentially important observation 
merits further investigation. (4) Depolarization with 
high KC1, particularly in the absence of glucose, may 
self-limit excitatory amino acid and dopamine release 
because it lowers [ATP]. (5) Lack of glucose on its 
own does not lead to transmitter elease perhaps 
because the effect of a rise in [Ca2+]i is matched by 
that of a fall in [ATP]. Alternately, changes in either 
parameter may be too small to be of consequence on 
either exocytotic or non-exocytotic effiux. All of 
these results taken together show a tight interplay 
between changes in internal concentrations of cal- 
cium (Table 5) and ATP in controlling neurotrans- 
mitter homeostasis. 
Table 7 
Exocytotic (calcium-dependent) and non-exocytotic ( alcium-independent) neurotransmitter r lease under conditions of reduced [ATP] 
Condition Dopamine Aspartate Glutamate GABA Aspartate Glutamate GABA 
(5 min) A(CaZ+-Mg 2+ ) (15 min) J(Ca2 +-Mg 2+ ) 
(pmol/mg prot) (nmol/mg prot) 
Ca 2+ 
+ Glucose 10. I ± 0.5 
KCl 9.6 ± 1.0 
Rotenone 6.2 ± 1.6 
KCI + rotenone 10.9 ± 0.2 
- Glucose 12.6 ± 0.4 
KC1 9.2 ± 0.6 
Rotenone 22.0 ± 1.7 
KC1 + rotenone 19.3 ± 0.4 
Mg 2+ 
+Glucose 6.7 + 0.1 
KC1 5.3 ± 0.8 
Rotenone 2.3 ± 0.1 
KCI + rotenone 6.4 ± 0.9 
- Glucose 9.6 ± 1.3 
KC1 5.9 ± 0.1 
Rotenone 21.1 -- 2.0 
KC1 + rotenone 18.5 ± 0.7 
0.9 ± 0.1 1.6 ± 0.2 0.2 _+ 0.0 
4.3 8.2 _+ 0.2 14.7 ± 0.5 1.7 _+ 0.3 5.2 9.5 0.9 
3.9 2.7 +_ 0.2 7.4 ± 0.7 1.2 ± 0.2 1.6 3.3 1.0 
3.5 9.0 _+ 0.4 22.9 _+ 0.4 4.1 ± 0.3 3.4 6.0 1.9 
1.0 _+ 0.1 1.5 ± 0.2 0.2 ± 0.0 
3.3 11.6 _+ 0.9 9.9 ± 1.5 1.9 _+ 0.3 7.0 4.7 1.2 
0.9 6.6 ± 0.4 13.1 ± 0.7 5.3 -+ 0.3 0.8 1.2 1.9 
0.8 14.2 +_ 0.3 24.5 + 0.6 5.8 ± 1.0 2.0 0.2 1.2 
1.0 + 0.1 2.2 ± 0.0 0.2 ± 0.0 
2.8 _+ 0.2 5.1 _+ 0.2 0.8 _+ 0.3 
1.1 _+0.2 4.1 _+0.3 0.2_+0.0 
5.6 ± 0.2 16.9 _+ 0.2 2.2 _+ 0.5 
0.9 _+ 0.0 1.9 _+ 0.1 0.2 _+ 0.0 
4.6 ± 0.4 5.2 +_ 0.4 0.7 _+ 0.2 
5.8 ± 0.8 11.9 _+ 0.3 3.4 _+ 0.3 
12.2_+0.1 24.3_+ 1.5 4.6_+ 1.1 
Amino acids or dopamine released into the medium, and given as A between time 0 and the interval indicated (Erecifiska et al. [156]), 
were measured by HPLC (Jarrett et ah [162] and Pastuszko et al. [145], respectively). The amounts present in the medium at time 0 are 
listed above the A values. Results with Mg 2+ give non-exocytotic release while exocytotic release was calculated as A(Ca 2+- Mg 2+). 
All figures represent means ± S.E.M. for 3 experiments. 
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4.5. Stimulation of ion mo~'ements and energy pro- 
duction in synaptosomes 
In brain in vivo increased neuronal activity en- 
hances ion movements at the synapses. Electrical 
stimulation of synaptosomes is not an easy technique 
but activation of ion movements can be mimicked by 
channel openers such as veratridine or ionophores 
which exchange one ion for another. Monensin medi- 
ates an exchange of Na + for H + and leads to a gain 
in sodium and loss of protons (internal alkalinization) 
while nigericin exchanges K + for H ~ with resulting 
effiux of potassium and influx of protons (internal 
acidification). Although potassium loss is mediated 
directly only by nigericin, a fall in [K+]i also accom- 
panies the administration of veratridine and monensin 
(Table 5); the depolarization which ensues and a gain 
of calcium are the consequences of the use of all 
three compounds. Activation of ion movements leads 
to an enhancement of energy utilization and a de- 
crease in ATP level which, in turn, stimulates energy 
producing pathways, glycolysis and oxidative phos- 
phorylation (Table 4 and references). In most situa- 
tions, mitochondrial reactions provide the major pro- 
portion of the total amount. It is interesting, however, 
that independent activation of phosphofructokinase 
by a decrease in [H +] increases glycolysis to the 
extent that its contribution rises from below 10% 
(control, veratridine) to about 25% ([146]; Table 4, 
monensin). 
Treatment with all three compounds discussed 
above leads to an increase in energy generation, but 
the magnitude of the rise is greatest with veratridine, 
although changes in ion gradients (Table 5) and 
[ATP] (or [ATP]/[ADP]) (Table 4) are smaller with 
this channel opener than with either nigericin or 
monensin. Intuitively, one would expect he opposite 
behaviour, i.e., a larger stimulation of glycolysis and 
oxidative phosphorylation with a more pronounced 
decline in energy level. In addition, the stimulation of 
both energy producing pathways with all three com- 
pounds declines over time (Table 4) and coincides 
with a fall in [ATP] to a very low value (_< 1.0 
nmol/mg protein or 0.25 raM). These findings indi- 
cate that at some stage, the energy consumption rate 
for massive ion pumping must have greatly exceeded 
the velocity at which ATP could be supplied. The 
question which arises is whether this mismatch be- 
tween the demand and supply is the sole explanation 
or whether the newly created internal conditions con- 
tribute, in some way, to the impairment of energy 
generation mechanisms. 
In a search of factors which could curtail the 
activity of energy producing pathways, one can elimi- 
nate the substrates, glucose and oxygen, because both 
are in excess under the conditions used. Of a rather 
large number of the remaining possibilities (see above 
for the discussion of the regulatory factors of glycol- 
ysis and oxidative phosphorylation), three should be 
considered of potential importance. The first are the 
adenine nucleotides. In principle, the activities of 
both pathways are inhibited by ATP and stimulated 
by ADP. However, when the level of ATP fails to a 
very low value it should limit the activity of phos- 
phofructokinase and in particular hexokinase thus 
halting the metabolism of glucose and its contribution 
as a substrate for both cytosolic and mitochondrial 
ATP production. The observation that the concentra- 
tion of intrasynaptosomal ATP at which glycolysis is 
50% inhibited [35] is very close to the K m value of 
hexokinase for this nucleotide confirms this postulate. 
Moreover, during high rates of ATP utilization, [ADP] 
can also decline because the adenylate kinase reac- 
tion will consume it to maintain [ATP]. A fall in ADP 
to a very low level could limit the activity of the 
mitochondrial respiratory chain kinetically. The sec- 
ond factor is protons. They inhibit phosphofructoki- 
nase (albeit to a much smaller extent when the [ATP] 
is low; [147]), 2-oxoglutarate dehydrogenase [39] and 
the respiratory chain itself [97]. The third inhibitory 
effect may come from a fall in potassium which is 
required for maximal activity of pyruvate kinase [32] 
and pyruvate dehydrogenase [148]. The quantitative 
contributions from all these factors will be different 
in different situations. However, the qualitative out- 
come is the same: the consequences of massive ion 
movements can limit the activity of the ATP produc- 
ing pathways and even lead to their complete shut- 
down, with a consequent nerve-terminal failure. It is 
interesting that the fall in ATP and a rise in H + also 
decrease the activity of the Na/K  pump. These prop- 
erties of the pump provide a self-limiting mechanism 
which could reduce energy utilization. 
In conclusion, synaptosomal energy metabolism is
very closely geared towards maintenance and restora- 
tion of ion gradients, the key function of the nerve 
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ending. A limitation in energy production leads very 
rapidly to ion leakage because the Na+/K  + and the 
Ca 2 + pumps are directly dependent on ATP. During 
massive ion movements, even under aerobic condi- 
tions, the rate of ATP formation falls below that of its 
utilization, with a consequent decline in intracellular 
energy level. Changes in internal ion concentrations 
can negatively influence the rate of energy produc- 
tion: protons inhibit phosphofructokinase and 2-oxo- 
glutarate dehydrogenase, while lack of potassium de- 
creases activity of pyruvate kinase and pyruvate de- 
hydrogenase. 
5. Concluding remarks 
The brief review of the information presented in 
this article demonstrates that synaptosomes form a 
well-characterized and convenient model system 
which allows us to understand processes occurring in 
nerve endings, a distinct compartment of the nerve 
cell. Although the preparation is heterogeneous in
that it is composed of nerve endings from different 
types of neurons, when carefully isolated, it contains 
relatively few non-neuronal elements as demonstrated 
by morphological [149] and marker protein studies 
[57,150]. It is the opinion of the present authors that 
results from studies obtained on isolated synapto- 
somes reflect events which occur in this compartment 
in brain in vivo. Unfortunately, almost nothing can be 
said about similarities and/or  differences between 
nerve endings and neuronal cell bodies because of the 
lack of an appropriate model for the latter. Neurons 
in culture very rapidly acquire properties which they 
do not have in whole brain, such as high glycolytic 
rate. Thus the development of a pure and metaboli- 
cally viable preparation of nerve cell bodies is an 
urgent and challenging task because, undoubtedly, 
there must be large differences between the two 
compartments owing to their distinct functions and 
organizations. 
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